U.S. Must Maintain Investments In HIV Vaccine, Prevention Research
The Hill: Choosing the worst time to scale back AIDS research
Mitchell Warren, executive director of AVAC
“…For the first time, we can honestly talk about how to end the AIDS epidemic — and we have not only researchers, advocates, and trial participants to thank, but also American taxpayers. But we don’t yet have all the tools we need. That’s why it is dismaying that some members of Congress have chosen this moment to call for scaling back the nation’s investments in HIV research. Instead, we should be looking for ways to make these investments even more impactful, to continue leading the world into a future without AIDS…” (5/18).